BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 15981904)

  • 21. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
    Small BJ; Gagnon E; Robinson B
    Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
    Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical dementia: an Italian multicentre study on amnestic mild cognitive impairment.
    Perri R; Serra L; Carlesimo GA; Caltagirone C;
    Dement Geriatr Cogn Disord; 2007; 23(5):289-300. PubMed ID: 17356272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Neuroimaging in mild cognitive impairment].
    Fukuyama H
    Rinsho Shinkeigaku; 2006 Nov; 46(11):791-4. PubMed ID: 17432181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Forgetfulness and light cognitive impairment. What can the physician still tolerate?].
    Förstl H; Bickel H; Lautenschlager N; Riemenschneider M; Kurz A
    MMW Fortschr Med; 2001 Jun; 143(23):23-7. PubMed ID: 11460413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild cognitive impairment: believe it or not?
    Allegri RF; Glaser FB; Taragano FE; Buschke H
    Int Rev Psychiatry; 2008 Aug; 20(4):357-63. PubMed ID: 18925484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment.
    Teipel SJ; Born C; Ewers M; Bokde AL; Reiser MF; Möller HJ; Hampel H
    Neuroimage; 2007 Oct; 38(1):13-24. PubMed ID: 17827035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
    Barth S; Schönknecht P; Pantel J; Schröder J
    Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. False recognition helps to distinguish patients with Alzheimer's disease and amnestic MCI from patients with other kinds of dementia.
    Hildebrandt H; Haldenwanger A; Eling P
    Dement Geriatr Cogn Disord; 2009; 28(2):159-67. PubMed ID: 19696484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subjective memory complaints in Chinese subjects with mild cognitive impairment and early Alzheimer's disease.
    Lam LC; Lui VW; Tam CW; Chiu HF
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):876-82. PubMed ID: 16116581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive estimation impairment in Alzheimer disease and mild cognitive impairment.
    Levinoff EJ; Phillips NA; Verret L; Babins L; Kelner N; Akerib V; Chertkow H
    Neuropsychology; 2006 Jan; 20(1):123-32. PubMed ID: 16460228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers in preclinical Alzheimer's disease.
    Chong MS; Lim WS; Sahadevan S
    Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment.
    Tabert MH; Manly JJ; Liu X; Pelton GH; Rosenblum S; Jacobs M; Zamora D; Goodkind M; Bell K; Stern Y; Devanand DP
    Arch Gen Psychiatry; 2006 Aug; 63(8):916-24. PubMed ID: 16894068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
    Missonnier P; Deiber MP; Gold G; Herrmann FR; Millet P; Michon A; Fazio-Costa L; Ibañez V; Giannakopoulos P
    Neuroscience; 2007 Dec; 150(2):346-56. PubMed ID: 17996378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive complaint in mild cognitive impairment and Alzheimer's disease.
    Clément F; Belleville S; Gauthier S
    J Int Neuropsychol Soc; 2008 Mar; 14(2):222-32. PubMed ID: 18282320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers.
    Parnetti L; Lanari A; Silvestrelli G; Saggese E; Reboldi P
    Mech Ageing Dev; 2006 Feb; 127(2):129-32. PubMed ID: 16274728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amnestic mild cognitive impairment: difference of memory profile in subjects who converted or did not convert to Alzheimer's disease.
    Perri R; Serra L; Carlesimo GA; Caltagirone C;
    Neuropsychology; 2007 Sep; 21(5):549-58. PubMed ID: 17784803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired social cognition in mild Alzheimer disease.
    Bediou B; Ryff I; Mercier B; Milliery M; Hénaff MA; D'Amato T; Bonnefoy M; Vighetto A; Krolak-Salmon P
    J Geriatr Psychiatry Neurol; 2009 Jun; 22(2):130-40. PubMed ID: 19321881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Rusinek H; Li J; Tsui W; Saint Louis LA; Clark CM; Tarshish C; Li Y; Lair L; Javier E; Rich K; Lesbre P; Mosconi L; Reisberg B; Sadowski M; DeBernadis JF; Kerkman DJ; Hampel H; Wahlund LO; Davies P
    Neurobiol Aging; 2006 Mar; 27(3):394-401. PubMed ID: 16125823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroimaging in Alzheimer's disease: an overview].
    Masdeu J
    Rev Neurol; 2004 Jun 16-30; 38(12):1156-65. PubMed ID: 15229831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.